Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity

Nature Medicine volume 21, pages 1464–1472 (2015)Cite this article

Subjects

Abstract

The TAM receptors Tyro3, Axl and Mertk are receptor tyrosine kinases that dampen host innate immune responses following engagement with their ligands Gas6 and Protein S, which recognize phosphatidylserine on apoptotic cells. In a form of apoptotic mimicry, many enveloped viruses display phosphatidylserine on the outer leaflet of their membranes, enabling TAM receptor activation and downregulation of antiviral responses. Accordingly, we hypothesized that a deficiency of TAM receptors would enhance antiviral responses and protect against viral infection. Unexpectedly, mice lacking Mertk and/or Axl, but not Tyro3, exhibited greater vulnerability to infection with neuroinvasive West Nile and La Crosse encephalitis viruses. This phenotype was associated with increased blood-brain barrier permeability, which enhanced virus entry into and infection of the brain. Activation of Mertk synergized with interferon-β to tighten cell junctions and prevent virus transit across brain microvascular endothelial cells. Because TAM receptors restrict pathogenesis of neuroinvasive viruses, these findings have implications for TAM antagonists that are currently in clinical development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Mortality and viral burden in WT and TAM receptor-deficient mice after subcutaneous or intracranial infection with WNV.
Figure 2: BBB permeability in WT and TAM receptor–deficient mice.
Figure 3: Vulnerability, viral burden and BBB permeability in WT, Axl−/− and Mertk−/− mice after infection with LACV.
Figure 4: Analysis of barrier integrity in brain microvascular endothelial cells from Axl−/−Mertk−/− mice.
Figure 5: Mertk signaling tightens BMEC barriers and functions synergistically with IFN-β.
Figure 6: Enhanced BBB permeability occurs independently of Mertk expression on astrocytes and radio-sensitive cells.

Similar content being viewed by others

References

  1. Lemke, G. Biology of the TAM receptors. Cold Spring Harb. Perspect. Biol. 5, a009076 (2013).

    PubMed  PubMed Central  Google Scholar 

  2. Cosemans, J.M.E.M. et al. Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J. Thromb. Haemost. 8, 1797–1808 (2010).

    CAS  PubMed  Google Scholar 

  3. Prieto, A.L., Weber, J.L. & Lai, C. Expression of the receptor protein-tyrosine kinases Tyro3, Axl and Mer in the developing rat central nervous system. J. Comp. Neurol. 425, 295–314 (2000).

    CAS  PubMed  Google Scholar 

  4. Lew, E.D. et al. Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities. eLife 3, e03385 (2014).

    PubMed Central  Google Scholar 

  5. Caraux, A. et al. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat. Immunol. 7, 747–754 (2006).

    CAS  PubMed  Google Scholar 

  6. Paolino, M. et al. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature 507, 508–512 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Holland, S.J. et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 70, 1544–1554 (2010).

    CAS  PubMed  Google Scholar 

  8. Holland, S.J. et al. Multiple roles for the receptor tyrosine kinase Axl in tumor formation. Cancer Res. 65, 9294–9303 (2005).

    CAS  PubMed  Google Scholar 

  9. Fraineau, S. et al. The vitamin K–dependent anticoagulant factor, protein S, inhibits multiple VEGF-A–induced angiogenesis events in a Mer- and SHP2-dependent manner. Blood 120, 5073–5083 (2012).

    CAS  PubMed  Google Scholar 

  10. Angelillo-Scherrer, A. et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J. Clin. Invest. 115, 237–246 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B.A. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124–1136 (2007).

    CAS  PubMed  Google Scholar 

  12. Prasad, D. et al. TAM receptor function in the retinal pigment epithelium. Mol. Cell. Neurosci. 33, 96–108 (2006).

    CAS  PubMed  Google Scholar 

  13. Scott, R.S. et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207–211 (2001).

    CAS  PubMed  Google Scholar 

  14. Zagórska, A., Traves, P.G., Lew, E.D., Dransfield, I. & Lemke, G. Diversification of TAM receptor tyrosine kinase function. Nat. Immunol. 15, 920–928 (2014).

    PubMed  PubMed Central  Google Scholar 

  15. Sheridan, C. First Axl inhibitor enters clinical trials. Nat. Biotechnol. 31, 775–776 (2013).

    CAS  PubMed  Google Scholar 

  16. Graham, D.K., DeRyckere, D., Davies, K.D. & Earp, H.S. The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer. Nat. Rev. Cancer 14, 769–785 (2014).

    CAS  PubMed  Google Scholar 

  17. van den Brand, B.T. et al. Therapeutic efficacy of Tyro3, Axl and Mer tyrosine kinase agonists in collagen-induced arthritis. Arthritis Rheum. 65, 671–680 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Meertens, L. et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12, 544–557 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Bhattacharyya, S. et al. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe 14, 136–147 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Shibata, T. et al. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma. J. Immunol. 192, 3569–3581 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Subramanian, M. et al. An AXL–LRP-1–RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. J. Clin. Invest. 124, 1296–1308 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Daniels, B.P. et al. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio 5, e01476–14 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. McJunkin, J.E. et al. La Crosse encephalitis in children. N. Engl. J. Med. 344, 801–807 (2001).

    CAS  PubMed  Google Scholar 

  24. Wang, T. et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10, 1366–1373 (2004).

    CAS  PubMed  Google Scholar 

  25. Zhu, D. et al. Protein S controls hypoxic-ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine-1-phosphate receptor. Blood 115, 4963–4972 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Chung, W.-S. et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394–400 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Brinton, M.A. Replication cycle and molecular biology of the West Nile virus. Viruses 6, 13–53 (2013).

    PubMed  PubMed Central  Google Scholar 

  28. Lazear, H.M. et al. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci. Transl. Med. 7, 284ra59 (2015).

    PubMed  PubMed Central  Google Scholar 

  29. Sheehan, K.C. et al. Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (Ifnar-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26, 804–819 (2006).

    CAS  PubMed  Google Scholar 

  30. Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology. Nature 420, 629–635 (2002).

    CAS  PubMed  Google Scholar 

  31. Mahajan, N.P. & Earp, H.S. An SH2 domain–dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizaing guanine nucleotide–exchange factor action. J. Biol. Chem. 278, 42596–42603 (2003).

    CAS  PubMed  Google Scholar 

  32. Gautier, E.L. et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118–1128 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Ji, R. et al. TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation. J. Immunol. 191, 6165–6177 (2013).

    CAS  PubMed  Google Scholar 

  34. Tibrewal, N. et al. Autophosphorylation docking site Tyr867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-κB transcriptional activation. J. Biol. Chem. 283, 3618–3627 (2008).

    CAS  PubMed  Google Scholar 

  35. Brien, J.D., Uhrlaub, J.L. & Nikolich-Žugich, J. Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection. Eur. J. Immunol. 37, 1855–1863 (2007).

    CAS  PubMed  Google Scholar 

  36. Shrestha, B. & Diamond, M.S. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78, 8312–8321 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Purtha, W.E. et al. Antigen-specific cytotoxic Tlymphocytes protect against lethal West Nile virus encephalitis. Eur. J. Immunol. 37, 1845–1854 (2007).

    CAS  PubMed  Google Scholar 

  38. Li, Q., Lu, Q., Lu, H., Tian, S. & Lu, Q. Systemic autoimmunity in TAM triple-knockout mice causes inflammatory brain damage and cell death. PLoS ONE 8, e64812 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Burstyn-Cohen, T., Heeb, M.J. & Lemke, G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J. Clin. Invest. 119, 2942–2953 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Verma, A., Warner, S.L., Vankayalapati, H., Bearss, D.J. & Sharma, S. Targeting Axl and Mer kinases in cancer. Mol. Cancer Ther. 10, 1763–1773 (2011).

    CAS  PubMed  Google Scholar 

  41. Suárez, R.M. et al. Inhibitors of the TAM subfamily of tyrosine kinases: synthesis and biological evaluation. Eur. J. Med. Chem. 61, 2–25 (2013).

    PubMed  Google Scholar 

  42. Lu, Q. & Lemke, G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro3 family. Science 293, 306–311 (2001).

    CAS  PubMed  Google Scholar 

  43. Diamond, M.S., Shrestha, B., Marri, A., Mahan, D. & Engle, M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77, 2578–2586 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Samuel, M.A. et al. PKR and RNase L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80, 7009–7019 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Thackray, L.B. et al. Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. J. Virol. 86, 13515–13523 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Mehlhop, E. & Diamond, M.S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203, 1371–1381 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Diamond, M.S. et al. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198, 1853–1862 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Lazear, H.M. et al. Pattern recognition receptor MDA5 modulates CD8+ T cell–dependent clearance of West Nile virus from the central nervous system. J. Virol. 87, 11401–11415 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Thackray, L.B. et al. Interferon regulatory factor 5 (IRF5)-dependent immune responses in the draining lymph node protect against West Nile virus infection. J. Virol. 88, 11007–11021 (2014).

    PubMed  PubMed Central  Google Scholar 

  50. Howell, G.R. et al. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J. Clin. Invest. 122, 1246–1261 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by US National Institutes of Health (NIH) grants U19 AI083019 (M.S.D. and R.S.K.), R01 AI101400 (M.S.D. and G.L.), R01 NS052632 (R.S.K.) and R01 NS085296 (G.L.). J.J.M. was supported by an NIH training grant (T32-AR007279) and a Rheumatology Research Foundation Scientist Development Award. B.P.D. was supported by a National Science Foundation Graduate Research Fellowship (DGE-1143954) and an NIH predoctoral fellowship (F31-NS07866). E.D.L. was supported by postdoctoral fellowships from the Leukemia and Lymphoma Society and the Nomis Foundation. We thank A. Pekosz (Johns Hopkins University) for the original LACV strain.

Author information

Authors and Affiliations

  1. Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA

    Jonathan J Miner, Bimmi Shrestha, Jose L Proenca-Modena, Helen M Lazear, Robyn S Klein & Michael S Diamond

  2. Department of Anatomy and Neurobiology, Washington University School of Medicine, Saint Louis, Missouri, USA

    Brian P Daniels & Robyn S Klein

  3. Department of Genetics, Evolution and Bioagents, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil

    Jose L Proenca-Modena

  4. Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, California, USA

    Erin D Lew & Greg Lemke

  5. Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA

    Helen M Lazear

  6. Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA

    Matthew J Gorman, Robyn S Klein & Michael S Diamond

  7. Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, Missouri, USA

    Michael S Diamond

  8. The Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, Missouri, USA

    Michael S Diamond

Authors
  1. Jonathan J Miner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian P Daniels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bimmi Shrestha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jose L Proenca-Modena
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erin D Lew
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Helen M Lazear
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Matthew J Gorman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Greg Lemke
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Robyn S Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael S Diamond
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.J.M., B.P.D., H.M.L., G.L., R.S.K. and M.S.D. designed the experiments; J.J.M., B.P.D., B.S., J.L.P.-M., H.M.L. and M.J.G. performed the experiments; E.D.L. and G.L. contributed essential reagents; and J.J.M. and M.S.D. wrote the initial draft of the manuscript, with all other authors providing critical comments and editorial changes.

Corresponding author

Correspondence to Michael S Diamond.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–8 (PDF 2099 kb)

Source data

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miner, J., Daniels, B., Shrestha, B. et al. The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Nat Med 21, 1464–1472 (2015). https://doi.org/10.1038/nm.3974

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3974

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing